Research & Innovation

Research Grant Competition

DSM’s Research Strategy is intended to support research opportunities that meet the overall principles and strategic priorities for diagnostic services in Manitoba. DSM has developed guidelines, opportunities, and funding for research with a focus on Knowledge Translation leading to adoption and implementation of evidence based, clinical practice and patient outcome improvements.

DSM funds two categories of Research and Innovation Grants:

  • 4 Small Research and Innovation projects to a maximum of $15,000 each
  • 2 Major Research and Innovation projects to a maximum of $60,000 each

Proposals must be for research and innovation projects that can be completed within the 24 month period April 1, 2017 to March 31, 2019. The principal investigator must be a member of the medical or scientific staff of DSM and/or a University of Manitoba faculty member. Collaborations between DSM medical/scientific staff and University of Manitoba faculty are encouraged.

Proposal Deadline: {Next deadline will be in December 2018. Please check back}

  • GUIDELINES
  • APPLICATION FORM (please note: right-click and save the application form to your computer so you can complete the form electronically)

Further information can be obtained from:

Dr. Yvonne Myal
Director of Research and Innovation
Ph: 204-789-3874
Email: yvonne.myal@med.umanitoba.ca


2017 Research and Innovation Grant Recipients

Diagnostic Services Manitoba is pleased to announce the awardees in the 2017 Research and Innovation Grant Competition. The grants provide funding for research with a focus on knowledge translation leading to adoption and implementation of evidence- based clinical practice and patient outcome improvements.

This year, three projects received funding in the small grant category:

Creating a New Ovarian Cancer Pathology Resource for Research and Innovation in Manitoba

Principal Investigator: Dr. Mark Nachtigal (Biochemistry and Human Genetics, University of Manitoba and Senior Scientist, CancerCare Manitoba)
Co-Applicant: Dr. Cyrille Bicamumpaka (DSM/Pathology, University of Manitoba)

Project Summary:

The objective of this study is to build an ovarian cancer tissue microarray (TMA) that can be used as an innovative research tool to advance ovarian cancer research and diagnostic capabilities in Manitoba.

Scleraxis as a Biomarker for Cardiac Fibrosis in Hypertrophic Cardiomyopathy

Principal Investigator: Dr. Davindar Jassal (Radiology and Physiology, St Boniface Research Centre)

Co-Applicants: Drs. Ian Kirkpatrick (Radiology) and Michael Czubryt (Dept of Physiology, University of Manitoba)

Project Summary:

Sudden cardiac death (SCD) due to cardiovascular disease is a leading cause of death in Canada that is entirely preventable.  In people younger than 40 years, hypertrophic cardiomyopathy (HCM) is a common cause of SCD.  The objective of this study is to determine whether the scleraxis protein, which is a biomarker of cardiac fibrosis, is detectable and correlates with the incidence of cardiovascular disease in patients with HCM as seen in MRI images.

Prognostic Significance of Telomere Length in Follicular Lymphoma: A Population-Based Study

Principal Investigator: Dr. Michel Nasr (DSM, Pathology)

Co-Applicants: Drs. Arshad Ahsanuddin (DSM, Pathology) and Anamarija Perry (DSM, Dept of Pathology, University of Manitoba)

Project summary:

This study aims to evaluate telomere length (TL) in a group of de novo follicular lymphoma (FL) patients in Manitoba.  The prognostic significance of telomere length in FL patients treated with chemotherapy, as well as the correlation of telomere length with other clinical parameters and immunohistochemical markers, will be assessed.